Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000164037 | SCV000214643 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001087268 | SCV000558613 | benign | Ataxia-telangiectasia-like disorder | 2023-12-09 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000859260 | SCV001144548 | benign | not provided | 2019-07-15 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000164037 | SCV002538434 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-21 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000859260 | SCV004220928 | benign | not provided | 2023-08-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003945281 | SCV004761573 | likely benign | MRE11-related condition | 2019-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |